812.21 HMGLPTHLATER

CH

Art. 33 Legge federale del 15 dicembre 2000 sui medicamenti e i dispositivi medici (LATer)

LATer; Capitolo 2: Medicamenti

Apri la fonte ufficiale Atto completo (141 Articoli) Versione Markdown leggibile dalle macchine (.md)

Art. 33 LATer

← Art. 32 LATer Legge federale del 15 dicembre 2000 sui medicamenti e i dispositivi medici (LATer) - Scopo Art. 33a LATer →

Decisioni giudiziarie che applicano questa disposizione (4)

501 2011 83 · fr (Art. 33 Abs. 2 i.V.m. Art. 87 Abs. 1 lit. b HMG)

Appellant v. Canton and Federal Authority: Compensation for Criminal Defense Costs and Dismissal of Loss Claims

Although cited in point D regarding Swissmedic's appeal, it is not explicitly cited in the final dispositive orders (I, II, III).

C-1663/2007 (Art. 33 HMG)

Pharmaceutical Company's Illegal Inducements to Doctors

Used as the legal basis to determine that the marketing action constituted an illicit monetary advantage.

C-669/2008 (Art. 33 Abs. 3 Bst. b HMG)

Pharmaceutical Wholesaler's Customer-Specific Conditions Ruled Illegal Financial Advantages

This provision is cited as the legal basis for allowing certain discounts, but its application is challenged and ultimately modified in the court's decision regarding the scope of the notification requirement.

VB.2011.00577 · zh (Art. 33 HMG)

Physicians' Mail-Order Pharmacy Model Challenged Over Dispensing Bans

This provision is cited in the list of legal norms, implying its relevance to the court's decision, although the specific application is not detailed in the summary.